Immune Thrombocytopenia laboratory findings

Jump to navigation Jump to search

Immune Thrombocytopenia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Immune Thrombocytopenia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Immune Thrombocytopenia laboratory findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Immune Thrombocytopenia laboratory findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Immune Thrombocytopenia laboratory findings

CDC on Immune Thrombocytopenia laboratory findings

Immune Thrombocytopenia laboratory findings in the news

Blogs on Immune Thrombocytopenia laboratory findings

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Immune Thrombocytopenia laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Maryam Barkhordarian, M.D.[2]

Overview

An elevated/reduced concentration of serum/blood/urinary/CSF/other [lab test] is diagnostic of [disease name].

OR

Laboratory findings consistent with the diagnosis of [disease name] include [abnormal test 1], [abnormal test 2], and [abnormal test 3].

OR

[Test] is usually normal for patients with [disease name].

OR

Some patients with [disease name] may have elevated/reduced concentration of [test], which is usually suggestive of [progression/complication].

OR

There are no diagnostic laboratory findings associated with [disease name].

Laboratory Findings

There are no diagnostic laboratory findings associated with [disease name].

OR

*An isolated thrombocytopenia in peripheral blood smear (PBS) is diagnostic of ITP. As diagnosis of immune thrombocytopenia is diagnosis by exclusion, other abnormalities in PBS may indicate other disease rather than ITP, such as shistocytes in patients with TTP or HUS and leukocyte inclusion bodies in MYH9-related disease.

Indications of Bone marrow evaluation (including morphologic assessment, flowcytometry, cytogenetic testing) in ITP:

  • **age older than 60 years
  • **constitutional symptoms
  • **splenomegaly

*Flowcytometry is helpful in identifying patients with ITP secondary to CLL.

*Baseline quantitative immunoglobulin level;

**Low level of immunoglobulin may reveal conditions such as common variable immunodeficiency. Treatment of ITP in CVID is contraindicated.

  • anti platelet antibodies ( glycoprotein specific antibody) are non-specific and are high in both immune and non-immune thrombocytopenia.
  • ANA is indicated of chronic ITP in children.[1]

OR

[Test] is usually normal among patients with [disease name].

OR

Laboratory findings consistent with the diagnosis of [disease name] include:

  • [Abnormal test 1]
  • [Abnormal test 2]
  • [Abnormal test 3]

OR

Some patients with [disease name] may have elevated/reduced concentration of [test], which is usually suggestive of [progression/complication].

References

  1. Schmoldt A, Benthe HF, Haberland G (1975). "Digitoxin metabolism by rat liver microsomes" Check |url= value (help). Biochem Pharmacol. 24 (17): 1639–41. PMID doi.org/10.1182/blood-2009-06-225565 Check |pmid= value (help).

Template:WH Template:WS